Frontline Immunotherapy Treatment Options in Advanced or Metastatic Cutaneous Melanoma

Source: Onclive, June 2025

The OncLive Peer Exchange features a panel of oncology experts discussing advancements in treating metastatic melanoma. The discussion opens with a moderator introducing a group of nationally recognized specialists in melanoma and skin cancer from institutions across the United States. Their collective goal is to share knowledge and strategies to help fellow clinicians better navigate the evolving treatment landscape, particularly focusing on the past decade’s progress in immunotherapy and cell therapies.

READ THE FULL ARTICLE

You must be logged in to post a comment.
Menu